Aaron Crittenden
President, Rx MarketplaceGoodRx
PresidentView Profile →President and Chief Commercial Officer · YPrime
President and Chief Commercial Officer of YPrime, the Malvern, Pennsylvania clinical trial technology company behind eCOA, IRT and eConsent platforms, where he directs commercial strategy across sales, business development and commercial operations. He joined in 2016 as Chief Commercial Officer and added the title of President in 2018, after senior commercial roles at Clariness, AdviseClinical and CRF Health.
Last reviewed: Sep 28, 2026
President and Chief Commercial Officer YPrime
Last Reviewed: September 28, 2026
Mark Maietta is President and Chief Commercial Officer of YPrime, a Malvern, Pennsylvania company that supplies the technology behind clinical trials: electronic clinical outcome assessment (eCOA), interactive response technology (IRT) for randomisation and drug supply, and eConsent. He joined in 2016 as Chief Commercial Officer and in August 2018 was also named President, taking responsibility for the strategic direction of the company’s growth. Today he directs YPrime’s commercial strategy, with oversight of sales, business development and commercial operations, and works under a separate Chief Executive Officer. His career of nearly three decades has been spent almost entirely on the commercial side of life sciences services and technology.
Maietta studied marketing at Ithaca College and later earned an MBA from Binghamton University. His early career was in the pharmaceutical industry itself and the data businesses around it, with positions at Pfizer, Novartis Pharmaceuticals and OPTUMInsight, now part of UnitedHealth Group.
In July 2012 CRF Health, a provider of electronic patient-reported outcome technology for clinical trials, appointed him Senior Vice President for Global Business Development and a member of its executive team. YPrime describes his tenure there as a period in which he redesigned business development and marketing practices and helped to build a global industry leader. He then became Chief Business Officer at AdviseClinical, a clinical strategic advisory and staffing firm, and after that Chief Commercial Officer of Clariness, which provides digital patient recruitment and engagement services. At Clariness he built and led the global commercial infrastructure.
He joined YPrime in 2016 as Chief Commercial Officer. YPrime, founded in 2006 by Shawn Blackburn, had grown from eClinical systems for patient management, clinical supplies and drug accountability into cloud-based IRT and eCOA platforms. A Form D filed with the SEC in November 2017 lists Maietta as one of the company’s executive officers. In August 2018 YPrime announced that he would also serve as President. Blackburn, then chief executive, said Maietta’s record of delivering results and building high-growth businesses would help the company adapt as digital health changed clinical research.
YPrime’s leadership has changed since then. Ian Lennox is now Chief Executive Officer and Blackburn serves as Founder and Director. Maietta continues as President and Chief Commercial Officer, leading the commercial side of a business that now covers eCOA, IRT, eConsent and participant engagement for sponsors and contract research organisations.
Binghamton University
MBA
Ithaca College
BS, Marketing